This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics

Sponsored by Kasey Phifer

About this trial

Last updated 3 years ago

Study ID

PEMF-BRI-Lyme-Disease-2020

Status

Terminated

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
14+ Years
All
All

Trial Timing

Ended 4 years ago

What is this trial about?

Overview PEMF Therapy for relief or reduction of lingering symptoms after antibiotic treatment of Lyme disease of participants in the UK. Symptoms monitored: Muscle ache, myalgia, muscle pain that is acutely located and/or 'wandering' (different location on different days) Aching joints Headache Fatigue, general tiredness, loss of energy, general exhaustion Mild, recurrent fever and/or chills occurring regularly Lack of oxygen in blood, feelings of 'air hunger', too high carbon dioxide levels in blood

What are the participation requirements?

Yes

Inclusion Criteria

- Diagnosis from GP confirming Lyme disease and/or

- Blood test confirming Lyme disease and/or

- Symptoms that correlate to Lyme disease without diagnosis from GP. This is called "self diagnosis" and because 80% of the trial is focused on treating symptoms and not the spirochetes, bacteria or small cysts of Lyme disease, the results are expected to be largely the same

No

Exclusion Criteria

- Persons currently undergoing antibiotic treatment for Lyme or other conditions

- Persons who were prescribed antibiotics but did not or could not take them

Locations

Location

Status